Unraveling systemic responses to NQO1-activated IB-DNQ and Rucaparib single and dual agent therapy in triple-negative breast cancersAvery M. Runnebohm, Amber L. Mosley|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0